Equillium, Inc.

NASDAQ:EQ

Biotechnology

Healthcare
$1.12 +1.51%

+$0.05 today

Market cap
$92.20M
Beta
1.76
P/E (TTM)
-15.3
EPS (TTM)
-$0.20
52W Low $0.27High $3.45

Volume 0.60M

Average 0.60M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$22.75M

FY 2025 · Annual

Investing Cash Flow

$4.46M

FY 2025 · Annual

-67.7% YoY

Financing Cash Flow

$30.43M

FY 2025 · Annual

+18453.0% YoY

Cash Flow Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Net Income(39.05M)(62.43M)(13.34M)(8.07M)(22.4M)
Depreciation & Amortization72K118K126K137K116K
Deferred Income Tax554K0000
Stock-Based Compensation4.41M4.84M4M3.75M2.32M
Change in Working Capital1.7M19K(2.55M)842K(2.32M)
Accounts Receivables0(2.84M)(897K)3.74M0
Inventory00000
Accounts Payables(1.58M)2.51M723K(2M)(1.94M)
Other Working Capital3.28M349K(2.37M)(898K)(380K)
Other Non-Cash Items237K48.72M(10.03M)(15.69M)(469K)
Operating Cash Flow(32.08M)(8.73M)(21.78M)(19.03M)(22.75M)
Capital Expenditures(57K)(279K)(50K)(85K)(48K)
Acquisitions (Net)0700K0012K
Purchases of Investments(32.99M)(14.96M)(54.71M)(17.6M)0
Sales of Investments60.46M33.23M50M31.5M4.5M
Other Investing Activities00000
Investing Cash Flow27.41M18.68M(4.76M)13.81M4.46M
Debt Repayment0(1.43M)(9.13M)00
Common Stock Issued29.91M214K0164K30.43M
Common Stock Repurchased00(260K)00
Dividends Paid00000
Other Financing Activities1.15M0165K00
Financing Cash Flow31.06M(1.22M)(9.23M)164K30.43M
Effect of Forex Changes(2K)5K(118K)(83K)47K
Net Change in Cash26.38M8.74M(35.89M)(5.13M)12.19M
Free Cash Flow(32.14M)(9.01M)(21.83M)(19.11M)(22.79M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$22.4M
+ D&A$116.0K
+ Stock-Based Comp$2.3M
+ Deferred Tax$0
- Working Capital-$2.3M
- Other Non-Cash-$469.0K
= Operating Cash Flow-$22.7M
- Capex-$48.0K
= Free Cash Flow-$22.8M

Analysis

FY2025 free cash flow is -$22.8M. FCF conversion is 101.8% of net income. Operating cash flow was -$22.7M, with capex of -$48.0K. The largest bridge item is Stock-Based Comp at $2.3M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
S-3S-3 filingNov 12, 2026
10-QQuarterly reportNov 12, 2026
8-KCurrent reportNov 12, 2026
SC 13G/ASC 13G/A filingNov 12, 2026

Does EQ generate free cash flow?

Equillium, Inc. (EQ) generated -$22.79M of free cash flow in fiscal 2025.

How much operating cash flow does EQ produce?

Operating cash flow was -$22.75M, before capital expenditures of $48,000.00.